找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Resistance to Targeted Therapies in Multiple Myeloma; Silvia CW Ling,Steven Trieu Book 2021 Springer Nature Switzerland AG 2021 multiple m

[复制链接]
楼主: 胃口
发表于 2025-3-26 21:34:28 | 显示全部楼层
Caroline Dix,Christian Bryanthird reading.Introduces applications to astronomyGeometry is probably the most accessible branch of mathematics, and can provide an easy route to understanding some of the more complex ideas that mathematics can present. This book is intended to introduce readers to the major geometrical topics taug
发表于 2025-3-27 01:29:53 | 显示全部楼层
发表于 2025-3-27 08:51:59 | 显示全部楼层
发表于 2025-3-27 11:22:51 | 显示全部楼层
2196-5501 res chapters written by internationally-based leaders in the.Multiple Myeloma remains an incurable malignancy. As the disease progresses, it invariably becomes resistant to treatment and almost all patients develop refractory disease. There are multiple different types of targeted therapies and many
发表于 2025-3-27 13:53:24 | 显示全部楼层
发表于 2025-3-27 19:27:31 | 显示全部楼层
发表于 2025-3-27 22:55:11 | 显示全部楼层
发表于 2025-3-28 05:02:12 | 显示全部楼层
发表于 2025-3-28 10:03:19 | 显示全部楼层
发表于 2025-3-28 11:46:21 | 显示全部楼层
Mechanisms Driving Resistance to Proteasome Inhibitors Bortezomib, Carfilzomib, and Ixazomib in Mulecome a mainstay of myeloma therapy, significantly enhancing the overall survival of patients. However, bortezomib resistance continues to be a significant hurdle in the treatment of MM, despite the introduction of next-generation PIs such as carfilzomib and ixazomib. Unlike resistance to some other
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-26 09:31
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表